Laser Capture Microdissection Market

Global Laser Capture Microdissection Market:

The global laser capture microdissection market size reached US$ 148.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 329.3 Million by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032. The increasing demand for personalized medicines, expanding cancer research, significant growth in biomarker discovery, and advancements in drug development are primarily propelling the market's growth.

Laser Capture Microdissection Market Analysis:

• Major Market Drivers: The growing utilization of molecular analysis in a bioscience research laboratory, along with the expanding healthcare industry, represent some of the key factors driving the market. Moreover, as LCM allows precise vivo examination of cell populations, such as malignant cells of Hodgkin's disease and carcinoma in situ with sensitive analytical techniques, its sales are rising across the globe.
• Key Market Trends: There is an increase in healthcare expenditure and R&D funding by governments of several countries. This, along with the escalating demand for LCM in forensic science and molecular biology centers to obtain interpretable DNA profiles, is stimulating the market growth. Moreover, key market players are introducing enhanced LCM technologies equipped with immunofluorescence laser diodes for improved biomarker discovery and cancer chemoprevention, which is projected to bolster the growth of the market.
• Competitive Landscape: Some of the prominent laser capture microdissection market companies include AnaPath Services GmbH (ST Pharm Co. Ltd), Bio-RAD Laboratories Inc., Caresbio Laboratory LLC, Carl Zeiss Meditec AG (Carl Zeiss AG), Epistem Ltd, Fluidigm Corporation, Gnome Diagnostics LLC, HÜBNER Photonics, Leica Microsystems GmbH (Danaher Corporation), Molecular Machines & Industries, Thermo Fisher Scientific Inc., and VitroVivo Biotech, among many others.
• Geographical Trends: According to the laser capture microdissection market dynamics, North America dominates the overall market. Genomic and proteomic research, especially related to genetic disorders, is expanding in North America. LCM facilitates these studies by enabling researchers to collect cells with minimal contamination, which is crucial for DNA, RNA, and protein analysis.
• Challenges and Opportunities: The high cost of instruments and increasing competition among alternative technologies are hampering the market's growth. However, the increasing focus on genomic and proteomic analysis to study cellular mechanisms, especially in diseases like cancer, neurological disorders, and rare genetic diseases, presents a significant opportunity for LCM.
   

Laser Capture Microdissection Market Trends:

Rising Incidence of Cancer

The rising incidence of cancer and other chronic diseases has increased the need for precise cellular analysis. There has been a significant number of cancer patients across various regions. For instance, according to American Cancer Society Journals, in 2024, the United States is expected to see 2,001,000 new cancer cases and 611,700 cancer deaths. LCM is used extensively to capture and study cancerous cells, especially for tumor profiling, genetic mutations, and other diagnostic purposes. These factors are expected to propel the laser capture microdissection market share in the coming years.

Expanding Biobanking Industry

The growing biobanking industry is one of the key factors driving the market growth. For instance, according to IMARC, the global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. Biobanks store vast amounts of biological samples, which researchers use for studying disease mechanisms, drug development, and biomarker discovery. LCM is critical for preparing these samples by enabling the precise isolation of specific cells from heterogeneous tissue samples. These factors further positively influence the laser capture microdissection market price.

Increasing Investment in R&D

Governments, research institutions, and private companies are heavily investing in R&D to advance precision medicine and genomics. For instance, in September 2024, TVM Capital Healthcare, an international growth capital firm focused on healthcare, made a significant equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global precision medicine and longevity science company. LCM technology plays a pivotal role in precision medicine areas, as it enables researchers to isolate specific cells for genetic analysis and study of disease mechanisms. The precision of LCM supports the development of personalized treatment plans, making it a key tool in genomic research, thereby boosting the laser capture microdissection market revenue.

Global Laser Capture Microdissection Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global laser capture microdissection market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, system type, application, and end user.

Breakup by Product:

• Instruments
• Consumables
• Software and Services
   

The report has provided a detailed breakup and analysis of the laser capture microdissection market based on the product. This includes instruments, consumables, and software and services. 

According to the laser capture microdissection market outlook, instruments form the core of LCM technology, including the laser systems, microscopes, and automation tools that enable precise cell and tissue capture. Modern LCM instruments have become more advanced with features like high-resolution imaging, automated sample handling, and integration with other lab equipment. The demand is driven by the need for these sophisticated tools that enhance precision, speed, and efficiency in capturing cells from complex tissues. Moreover, consumables are essential for daily research and experimental activities in genomics, proteomics, and cell biology. The growing number of research projects in universities, research institutions, and biotech companies increases the demand for LCM consumables.

Breakup by System Type:

• Ultraviolet LCM
• Infrared LCM
• Others
   

Ultraviolet LCM currently holds the majority of the total market share

The report has provided a detailed breakup and analysis of the laser capture microdissection market based on the system type. This includes ultraviolet LCM, infrared LCM, and others. According to the report, ultraviolet LCM currently holds the majority of the total market share.

According to the laser capture microdissection market overview, UV LCM technology is known for its high precision in cutting and capturing cells with minimal thermal damage to the surrounding tissues. This makes it ideal for applications where maintaining cell integrity is crucial, such as in genetic and molecular analysis. Moreover, neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis require the analysis of specific neurons and brain tissue regions. UV LCM is widely used in neuroscience research to dissect precise areas of brain tissues, enabling researchers to study disease pathology at the cellular level.

Breakup by Application:

• Research and Development
• Diagnostics
• Others
   

Research and development exhibits clear dominance in the market

The report has provided a detailed breakup and analysis of the laser capture microdissection market based on the application. This includes research and development, diagnostics, and others. According to the report, research and development exhibits a clear dominance in the market.

LCM technology is highly valued in genomics research for isolating pure cell populations to perform DNA, RNA, and protein analysis. The precision offered by LCM is essential for generating high-quality data in genetic sequencing, transcriptomics, and epigenetic studies, driving its adoption in R&D. Moreover, precision medicine aims to develop tailored treatment strategies based on an individual’s genetic makeup and cellular characteristics. LCM supports these efforts by providing specific cell samples that are crucial for understanding patient-specific disease mechanisms and drug response, driving its increased use in R&D.

Breakup by End User:

• Hospitals
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
   

Academic and government research institutes account for the largest market share

The report has provided a detailed breakup and analysis of the laser capture microdissection market based on the end user. This includes hospitals, academic and government research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). According to the report, academic and government research institutes account for the largest market share.

Academic and government research institutes are at the forefront of exploring fundamental biological processes. LCM plays a critical role in isolating specific cells from complex tissues, allowing researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Moreover, cancer research is a major focus in both academic and government research institutions. LCM is a key tool for isolating cancer cells from surrounding tissues to study tumor heterogeneity, gene mutations, and the molecular mechanisms driving cancer progression. As these institutions receive substantial government funding for cancer research, the demand for LCM technology rises.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the laser capture microdissection market statistics, North America, especially the United States, is a global leader in personalized medicine. LCM technology plays a critical role in isolating specific cells from tissues for genomic and molecular analysis, which is essential for tailoring treatment to individual patients. The increasing focus on personalized healthcare is driving the demand for LCM technology in both research and clinical settings. Moreover, LCM is widely used for tumor profiling, identifying cancer biomarkers, and studying tumor microenvironments, which are key to developing personalized cancer treatments. The rising adoption of precision oncology across North America is a significant growth driver for the LCM market.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: 

• AnaPath Services GmbH (ST Pharm Co. Ltd)
• Bio-RAD Laboratories Inc.
• Caresbio Laboratory LLC
• Carl Zeiss Meditec AG (Carl Zeiss AG)
• Epistem Ltd
• Fluidigm Corporation
• Gnome Diagnostics LLC
• HÜBNER Photonics
• Leica Microsystems GmbH (Danaher Corporation)
• Molecular Machines & Industries
• Thermo Fisher Scientific Inc.
• VitroVivo Biotech
   

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Laser Capture Microdissection Market Recent Developments:

• October 2024:  Elliott Institute of Technology Los Angeles (EIT Los Angeles), an interdisciplinary research center focused on cancer and global health, successfully deployed Sapio Sciences' Laboratory Information Management System (LIMS) to streamline complex cancer research operations and accelerate scientific discovery. LCM assists in cancer research by enabling scientists to isolate and analyze specific cancerous cells or regions from complex tissue samples with high precision.
• August 2024: Median Technologies signed an agreement with a top 10 cancer pharmaceutical company. The partnership seeks to do AI-based imaging biomarker identification using clinical data for a therapeutic candidate. LCM aids in the identification and validation of biomarkers.
• November 2023: Laxco launched Accuva Cellect Laser Capture Microdissection (LCM System). This revolutionary method is meant to isolate and capture single cells with exceptional accuracy, hence boosting research and analysis.

Laser Capture Microdissection Market Report Scope:

Key Benefits for Stakeholders:

• IMARC's report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the laser capture microdissection market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global laser capture microdissection market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the laser capture microdissection industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.